PeterMichaelVarunokMD

Gastroenterology • Poughkeepsie, NY

Physician

Join to view full profile

Dr. Varunok is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Varunok's full profile

Already have an account?

Office
243 North Rd
Ste 304
Poughkeepsie, NY 12601
Phone+1 845-471-9410

Fax+1 845-451-7757

Education & Training

New York Medical College at St Vincent's Hospital and Medical Center of New YorkFellowship, Gastroenterology, 1991 - 1993
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1988 - 1991
State University of New York Downstate Medical Center College of MedicineClass of 1988

Certifications & Licensure

NY State Medical License 1990 - 2025
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

Fellow ACG, 2020
CMS Meaningful Use Stage 1 Certification MEDENT EMR/EHR, Community Computer Service, Inc., 2011-2013
Fellow (AGAF) American Gastroenterological Association, 2006

Clinical Trials

Efficacy and Safety Study of Oral Eligen® B12 in Subjects With Low Serum Cobalamin Start of enrollment: 2009 Feb 01
Completed
Not Applicable
The Plecanatide Chronic Idiopathic Constipation (CIC) Study Start of enrollment: 2011 Oct 01
Completed
Phase 2, Phase 3
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC) Start of enrollment: 2013 Aug 01
Completed
Phase 3
Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis Start of enrollment: 2014 Mar 27
Completed
Phase 3
Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis Start of enrollment: 2014 Apr 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

66 citations
Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-Label Study of Patients With Genotype 1b Chronic Hepatitis C Virus Infection With and Without...
Eric Lawitz, Mihály Makara, Ulus Salih Akarca, Paul J. Thuluvath, Liliana Preotescu
Gastroenterology. 2015-10-01
103 citations
Ombitasvir/paritaprevir/r and dasabuvir plus ribavirin in HCV genotype 1-infected patients on methadone or buprenorphine
Jacob Lalezari, J. Greg Sullivan, Peter Varunok, Edward Galen, Kris V. Kowdley
Journal of Hepatology. 2015-08-01
492 citations
All-Oral 12-Week Treatment With Daclatasvir Plus Sofosbuvir in Patients With Hepatitis C Virus Genotype 3 Infection: ALLY-3 Phase III Study
David R. Nelson, James N. Cooper, Jacob Lalezari, Eric Lawitz, Paul J. Pockros
Hepatology. 2015-04-01

Press Mentions

Health: Should I Be Tested for Hepatitis C?September 12th, 2017

Professional Memberships